Ronald King

A novel drug that glues cancer proteins to the cellular trash system has entered human trials, offering new hope for rare diseases like Ewing sarcoma.

As part of a $23B US investment, Novartis will build a cutting-edge facility in Winter Park, cementing Florida’s role in advanced cancer treatment.

A top luxury planner is trading Zoom calls for Swiss Alps adventures, letting couples "test-drive" their destination wedding before they say "I do."

With a major Series B led by IDG Capital, PhotonPay is accelerating its mission to re-architect global payments with a stablecoin-native infrastructure.

After its stock soared on a Starlink deal, private jet operator flyExclusive announced a public offering, balancing growth ambitions with market risk.

Chase will become the new issuer for Apple Card, inheriting a $20B portfolio in a move that signals a major shift in the digital finance landscape.

Caterpillar unveils its Cat AI Assistant and NVIDIA partnership at CES, launching autonomous construction gear and a $25M plan to upskill its workforce.

BizClik’s Net Zero Summit will feature an SGS workshop to help leaders turn complex ESG regulations into a strategic advantage amid global compliance shifts.

Backed by Frazier Healthcare Partners, the new CareTria aims to slash patient wait times for medication with a powerful, end-to-end technology platform.

A new 'RaiseWell Certified' label for beef just launched, promising total traceability and higher ethical standards. But will it finally clear up consumer confusion?

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

A new partnership between Second Front Systems and Paramify leverages automation to slash software compliance times from years to months for government agencies.

In 2025, A&G saved retailers like Rite Aid and expanded its expertise to healthcare and life sciences, showcasing the power of strategic real estate.

The FinTech firm's multiple 'Best Places to Work' honors highlight a key strategy for winning the fierce competition for top AI and technology talent.

Elevest Capital acquires a 240-unit complex, signaling a strategic push to modernize older assets amid Charlotte's record construction and shifting rents.

Priestly Demolition appoints an external CEO and promotes internal leaders, a strategic move to blend new expertise with its family legacy for major expansion.

Circle Pharma will unveil its pipeline of novel oral macrocycle drugs targeting elusive cancer drivers at the influential J.P. Morgan Healthcare Conference.

EMERGE Commerce CEO Ghassan Halazon unveils a new strategy, detailing past growth errors and a multi-year turnaround that pivots the firm to disciplined growth.

The acquisition of seven Kloeckner service centers marks a major strategic push, expanding Russel Metals' U.S. footprint and value-added capabilities.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.